Search
Categories
Hot topics close

Nirsevimab use may reduce infant hospitalizations due to RSV by 82 percent: Lancet

Nirsevimab use may reduce infant hospitalizations due to RSV by 82 percent Lancet
Nirsevimab use may reduce infant hospitalizations due to respiratory syncytial virus (RSV) by 82 percent, shows real world evidence published in The Lancet. The findings are from the first RSV...

Nirsevimab use may reduce infant hospitalizations due to RSV by 82 percent: Lancet

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
Similar news
News Archive
  • Antidepressant
    Antidepressant
    Maddy felt 'brain zaps' after stopping antidepressants. No-one told her they were a common symptom of withdrawal
    30 Jan 2024
    3
  • OFX
    OFX
    OFX Group to Acquire Canadian FX Firm Firma for $69.6M
    20 Dec 2021
    2
  • Shalini Passi
    Shalini Passi
    Shalini Passi gets surprise call from son during interview. Here's ...
    27 days ago
    4
  • Taylor Swift tickets
    Taylor Swift tickets
    It's almost Swiftstravaganza time: Here's everything you need to ...
    13 Feb 2024
    5